Literature DB >> 15609500

The many mechanisms of viral membrane fusion proteins.

L J Earp1, S E Delos, H E Park, J M White.   

Abstract

Every enveloped virus fuses its membrane with a host cell membrane, thereby releasing its genome into the cytoplasm and initiating the viral replication cycle. In each case, one or a small set of viral surface transmembrane glycoproteins mediates fusion. Viral fusion proteins vary in their mode of activation and in structural class. These features combine to yield many different fusion mechanisms. Despite their differences, common principles for how fusion proteins function are emerging: In response to an activating trigger, the metastable fusion protein converts to an extended, in some cases rodlike structure, which inserts into the target membrane via its fusion peptide. A subsequent conformational change causes the fusion protein to fold back upon itself, thereby bringing its fusion peptide and its transmembrane domain-and their attached target and viral membranes-into intimate contact. Fusion ensues as the initial lipid stalk progresses through local hemifusion, and then opening and enlargement of a fusion pore. Here we review recent advances in our understanding of how fusion proteins are activated, how fusion proteins change conformation during fusion, and what is happening to the lipids during fusion. We also briefly discuss the therapeutic potential of fusion inhibitors in treating viral infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15609500      PMCID: PMC7122167          DOI: 10.1007/3-540-26764-6_2

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  216 in total

1.  N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil.

Authors:  J Chen; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.

Authors:  Richard J Kuhn; Wei Zhang; Michael G Rossmann; Sergei V Pletnev; Jeroen Corver; Edith Lenches; Christopher T Jones; Suchetana Mukhopadhyay; Paul R Chipman; Ellen G Strauss; Timothy S Baker; James H Strauss
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

Review 3.  Influenza fusion peptides.

Authors:  J J Skehel; K Cross; D Steinhauer; D C Wiley
Journal:  Biochem Soc Trans       Date:  2001-08       Impact factor: 5.407

4.  Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement.

Authors:  R E Dutch; R A Lamb
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 5.  Membrane fusion.

Authors:  Reinhard Jahn; Thorsten Lang; Thomas C Südhof
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

6.  A new mechanism for the neutralization of enveloped viruses by antiviral antibody.

Authors:  S W Gollins; J S Porterfield
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

7.  Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation.

Authors:  Stéphane Bressanelli; Karin Stiasny; Steven L Allison; Enrico A Stura; Stéphane Duquerroy; Julien Lescar; Franz X Heinz; Félix A Rey
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

8.  Structural features of membrane fusion between influenza virus and liposome as revealed by quick-freezing electron microscopy.

Authors:  T Kanaseki; K Kawasaki; M Murata; Y Ikeuchi; S Ohnishi
Journal:  J Cell Biol       Date:  1997-06-02       Impact factor: 10.539

9.  Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus.

Authors:  M Kielian; M R Klimjack; S Ghosh; W A Duffus
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

10.  Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein.

Authors:  L D Hernandez; R J Peters; S E Delos; J A Young; D A Agard; J M White
Journal:  J Cell Biol       Date:  1997-12-15       Impact factor: 10.539

View more
  197 in total

1.  The transmembrane domain sequence affects the structure and function of the Newcastle disease virus fusion protein.

Authors:  Kathryn A Gravel; Lori W McGinnes; Julie Reitter; Trudy G Morrison
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Viral infection: Moving through complex and dynamic cell-membrane structures.

Authors:  Jonathan Barroso-González; Laura García-Expósito; Julià Blanco; Agustín Valenzuela-Fernández; Isabel Puigdomènech; Laura de Armas-Rillo; José-David Machado
Journal:  Commun Integr Biol       Date:  2011-07-01

3.  Features of a spatially constrained cystine loop in the p10 FAST protein ectodomain define a new class of viral fusion peptides.

Authors:  Christopher Barry; Tim Key; Rami Haddad; Roy Duncan
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

4.  Inhibition of hendra virus fusion.

Authors:  M Porotto; L Doctor; P Carta; M Fornabaio; O Greengard; G E Kellogg; A Moscona
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Functions of the stem region of the Semliki Forest virus fusion protein during virus fusion and assembly.

Authors:  Maofu Liao; Margaret Kielian
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

6.  Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH.

Authors:  Rachel M Schowalter; Stacy E Smith; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

7.  Site-directed antibodies against the stem region reveal low pH-induced conformational changes of the Semliki Forest virus fusion protein.

Authors:  Maofu Liao; Margaret Kielian
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

8.  Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex.

Authors:  Suany Ojeda; Arban Domi; Bernard Moss
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

9.  Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway.

Authors:  Alan C Townsley; Andrea S Weisberg; Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

10.  Anionic lipids are required for vesicular stomatitis virus G protein-mediated single particle fusion with supported lipid bilayers.

Authors:  Pedro M Matos; Mariana Marin; Byungwook Ahn; Wilbur Lam; Nuno C Santos; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.